Immunogenic and nondividing mafosfamide-treated L 1210 cells--comparison of lines resistant and nonresistant to cyclophosphamide

Folia Histochem Cytobiol. 1993;31(2):63-6.

Abstract

Cyclophosphamide/mafosfamide-resistant L 1210 cell line [L 1210(Cy)R] was established from a sensitive parental line. The L 1210(Cy)R line was resistant to cyclophosphamide at the dose of 100 mg/kg. Cells of L 1210(Cy)R line were more immunogenic for semisyngeneic CD2F1, mice as compared with parental line. They grew slower in immunocompetent mice compared to immunosuppressed mice. It has been shown that L 1210(Cy)R cells treated with mafosfamide at high concentration not only retained immunogenicity but were even more immunogenic than parental L 1210 cells. In conclusion, it was possible to produce immunogenic, nondividing leukemia cells even when cells were resistant to the cytostatic used for cell modification.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Cell Division / drug effects
  • Cyclophosphamide / analogs & derivatives*
  • Cyclophosphamide / pharmacology*
  • Drug Resistance
  • Female
  • Immunization
  • Leukemia L1210 / drug therapy*
  • Leukemia L1210 / immunology*
  • Leukemia L1210 / prevention & control
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred DBA
  • Tumor Cells, Cultured / drug effects

Substances

  • Antineoplastic Agents
  • mafosfamide
  • Cyclophosphamide